Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Second Phase of Covid-19 Vaccinations Begins

06/16/2021 | 11:06am EDT

The second phase of the government's mass Covid-19 vaccination programme is expected to begin today at Scott Hospital, Morija.

Their Majesties King Letsie III and Queen 'Masenate Mohato Seeiso are among those expected to grace the official launch of the second phase. They will receive their second jabs.

They both attended the inaugural launch of the campaign in March this year and got their first jabs along with Prime Minister Moeketsi Majoro and other senior government officials.

One of the health ministry's coordinators of the vaccination programme, 'Mamonaheng Posholi, yesterday said only those who received their first jabs of the AstraZeneca vaccine when the programme began in March will be eligible for their second dose.

"All those who received their first jabs of the vaccine at various health centres in March must visit the same facilities for their second doses," Ms Posholi said.

"Those who have not received the first jabs will have to wait until after we have received a different vaccine for the purpose," she added.

This was in reference to the government's plans to switch to the Johnson & Johnson vaccines. Health Minister Sekatle recently said they would procure Johnson & Johnson vaccines because "they present less logistical challenges as people only have to be vaccinated once".

The launch of the second phase follows last week's delivery of 36 000 doses of the AstraZeneca vaccine donated by France. The vaccines were handed over to Mr Sekatle and World Health Organisation (WHO) country representative, Richard Banda, by UNICEF country representative Anurita Bains.

Mr Sekatle said Lesotho was expecting more vaccines from the African Union (AU) and a donation of over 100 000 vaccines from China. The arrival of more doses will enable those who are yet to be vaccinated to be jabbed.

Lesotho received the first batch of AstraZeneca vaccines on 3 March 2021. The 36 000 doses enabled the government to roll out its mass vaccination programme a week later.

After the government leaders were jabbed, the vaccination campaign was then spread to essential workers such as health workers and media practitioners. The ministry also vaccinated the elderly and those with life-threatening conditions like HIV/AIDS and tuberculosis.

These groups will receive their second and final doses of the vaccines during the second phase of the vaccination programme.

People in Maseru will start getting vaccinated today with the Berea and Mafeteng districts following tomorrow.

People in other districts will start getting vaccinated on Monday.

FacebookTwitterGoogle+ReddItWhatsAppPinterestEmail

Copyright Lesotho Times. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.46% 8491 Delayed Quote.15.78%
JOHNSON & JOHNSON 1.06% 171.79 Delayed Quote.9.16%
All news about ASTRAZENECA PLC
07/24DR Congo Faces Major Challenges in Covid-19 Vaccine Rollout
AQ
07/24ASTRAZENECA : scours supply chain for more vaccine doses for Thailand, SE Asia
RE
07/23PFIZER : Brazil reopens amid looming threat from delta variant
AQ
07/23Relaxed Border Restrictions For U.S. Travelers Coming August 9, 2021
AQ
07/23CORONAVIRUS – TUNISIA : Belgium sends emergency aid to Tunisia in the figh..
AQ
07/23ASTRAZENECA : Secures FDA Approval for Bydureon BCise Injectable Suspension for ..
MT
07/23AstraZeneca’s BYDUREON BCise Approves in the Us for the Treatment of Type 2 D..
CI
07/23AstraZeneca's Bydureon BCise Gets U.S. Approval For Type 2 Diabetes in Pediat..
DJ
07/23CORRECTION : AstraZeneca Says Data Shows One Dose of COVID-19 Jab 'Highly Effect..
MT
07/23ASTRAZENECA : Single-Dose COVID-19 Jab Shows Effect Against Beta, Gamma, Delta V..
MT
More news
Financials (USD)
Sales 2021 31 752 M - -
Net income 2021 4 669 M - -
Net Debt 2021 10 816 M - -
P/E ratio 2021 33,0x
Yield 2021 2,42%
Capitalization 181 B 181 B -
EV / Sales 2021 6,03x
EV / Sales 2022 5,25x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 116,57 $
Average target price 132,19 $
Spread / Average Target 13,4%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC15.78%155 197
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246